Appsilon Joins the Pharmaverse Council to Advance Open-Source Clinical Reporting

This article is originally published at https://appsilon.com

Appsilon’s core purpose is to advance technology to preserve and improve human life, and it translates into a unified set of values shared by the whole organization.

We realize this by creating and enhancing tools to solve the problems our clients are faced with, focusing on impact. We work with many leaders in the pharmaceutical and biotechnology sectors and take pride in helping them accelerate the discovery and provision of medicines.

With this in mind, we are all proud to announce that we are joining forces with the Pharmaverse Council, an influential organization dedicated to fostering collaborative, open-source software development for clinical reporting in the pharmaceutical industry.

Pharmaverse‘s mission is to streamline the drug development process by promoting open standards and interoperability between regulatory systems. By bringing together leading companies, academics, and regulatory bodies, the council facilitates collaboration and knowledge sharing to drive innovation in clinical data reporting.

A Shared Commitment to Open-Source Solutions

At the heart of Pharmaverse is developing a curated open-source suite of R packages to enable the entire clinical reporting data pipeline, from case report forms through to regulatory submissions. This approach can reduce duplicated efforts across the pharmaceutical industry and provide a smoother experience for regulators reviewing submissions.

At Appsilon, we have long championed the open-source philosophy, believing that collective knowledge, diverse opinions, and transparency are essential for meaningful progress. Joining the Pharmaverse Council strengthens our commitment to creating accessible tools that benefit the entire pharmaceutical ecosystem.

We actively create, maintain, and contribute to numerous open-source projects, such as our package, Rhino (a part of Pharmaverse), which is useful for streamlining FDA submissions.

Conclusion

We’re proud and excited to be part of the Pharmaverse Council. In embracing the spirit of open source and collaboration, we are committed to adopting shared solutions that accelerate the development of technology for improved clinical reporting and drug discovery.

We invite the community to engage with us as we continue to share our progress and insights through our blog posts and open-source contributions. ‍

Subscribe to our newsletter for updates on this exciting journey, and check out Pharmaverse’s new newsletter as well!

The post appeared first on appsilon.com/blog/.

Thanks for visiting r-craft.org
This article is originally published at https://appsilon.com
Please visit source website for post related comments.